Dopamine Receptor d1 Antikörper (4th Extracellular Domain)
Kurzübersicht für Dopamine Receptor d1 Antikörper (4th Extracellular Domain) (ABIN2255231)
Target
Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- 4th Extracellular Domain
-
Kreuzreaktivität
- Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Rt
-
Produktmerkmale
- Dopamine Receptor, D1a
-
Aufreinigung
- Purified by affinity chromatography.
-
Immunogen
- Synthetic peptide corresponding to 9aa from the 4th extracellular domain of rat D1a receptor. Species Sequence Homology: mouse, 100%, human, 88%, porcine, 77%
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.1 % BSA.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Andere Bezeichnung
- Dopamine Receptor, D1a
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-